Personnel Moves Archives - Page 24 of 42

Titan Medical names Cary G. Vance as new president, CEO

Titan Medical (Nasdaq:TMDI) announced that it appointed Cary G. Vance as its new president and CEO.

Vance will succeed Titan chair of the board of directors, Paul Cataford, who had served as interim president and CEO since December 2021, when David McNally, who previously held the corner office, resigned. Vance’s appointment was made effective today.

“After a thorough search and selection process using a top-tier recruiting firm and advisor, and after completing a rigorous leadership requirement and assessment analysis, we are pleased to announce that we have selected Cary as our next president and CEO. Cary brings extensive expertise and insights in robotic medical technology and minimally invasive surgery, filling this key leadership role,” Cataford said in a news release. “It was during the interim management period and the interviewing and assessment of a number of candidates that we determined the final requirements for our next president and CEO, an…

ResMed names Lucile Blaise as new Sleep & Respiratory Care leader

Lucile Blaise will become president of ResMed’s Sleep & Respiratory Care business on July 1. [Photo courtesy of ResMed]

Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today.

She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during the transition.

Blaise is ResMed’s VP of Sleep & Respiratory Care for Western Europe. She joined San Diego-based ResMed in 2006 and has more than 25 years of experience in medical device sales, marketing, finance, and business development, the company said in a news release.

Blaise serves on the MedTech Europe board and was elected president of French medtech association Snitem this month.

ResMed CEO Mick Farrell …

Inovio names new chief medical officer

Inovio (Nasdaq:INO) announced today that it appointed Dr. Michael Sumner as its new chief medical officer (CMO).

Sumner will oversee Inovio’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, along with regulatory affairs, pharmacovigilance and medical affairs.

He will also serve on the company’s executive leadership team and report to President and CEO Dr. Jacqueline Shea in his role at the Plymouth Meeting, Pennsylvania-based developer of vaccines and vaccine delivery technology.

Get the full story at our sister site, Drug Delivery Business News.

Medtronic appoints Lidia Fonseca as independent board director

Medtronic (NYSE:MDT) announced today that it appointed Lidia Fonseca to its board of directors as an independent director.

Fonseca, who serves as VP and chief digital and technology officer at Pfizer, will become a director effective today. She will serve on the board’s Compensation Committee and Science and Technology Committee.

“We are thrilled to welcome Lidia to Medtronic’s board of directors,” Medtronic Chair and CEO Geoff Marth said in a news release. “She has an impressive history of developing digital healthcare solutions that deliver powerful insights to improve patients’ lives. Her extensive knowledge and expertise will provide the Board with an important dimension and a tremendously valuable perspective as we drive toward our bold ambition to become the global leader in healthcare technology.”

With more than 30 years of experience in healthcare innovation, Fonseca currently holds responsibility for dev…

Vivera adds two industry veterans to its technology advisory board

The Zicoh drug delivery device. [Image from Vivera]Vivera announced today that it added Robert Massoudi and Bryan Hughes to its technology advisory board.

Massoudi and Hughes will support Newport Beach, California-based Vivera in its product and software development initiatives while forging strategic partnerships for Zicoh, the compnay’s electronic dose-controlled medication delivery system designed to improve prescription drug adherence, including medications with a higher propensity for misuse and abuse.

Get the full story at our sister site, Drug Delivery Business News.

Vektor Medical names Rob Krummen as CEO

Vektor Medical CEO Rob Krummen [Image courtesy of Vektor Medical]Vektor Medical this week announced that it appointed Rob Krummen as CEO.

Krummen previously served as president and chief operating officer of the San Diego-based company. He was responsible for the clinical, regulatory, engineering and operations and will continue to oversee the efforts while growing the company’s commercial and sales teams as CEO.

The company is developing vMap, a non-invasive cardiac arrhythmia mapping platform that takes less than three minutes to allow clinicians to input case information, upload and markup an ECG and receive a 3D interactive arrhythmia source location map to visualize the heart. Krummen’s appointment comes as the company transitions to a commercial company and focuses on the pilot roll-out of vMap.

“Vektor Medical has a unique opportunity to revolutionize the standard of care for arrhythmias, and I look forward to working hard alongside our b…

Owens & Minor appoints Tammy Gomez as chief human resources officer

Tammy Gomez, executive VP and chief human resources officer [Image courtesy of Owens & Minor]Owens & Minor (NYSE:OMI) today announced that it has appointed Tammy Gomez as executive VP and chief human resources officer, effective July 11.

Gomez will report directly to president and CEO Edward Pesicka and will come a member of the company’s executive leadership team. She will be responsible for teammate strategy and will oversee global human resources operations. Gomez will work with leadership on driving strategies for retaining, developing, engaging and attracting talent to the Richmond, Virginia-based company.

“Our teammates are the backbone of Owens & Minor, and I’m confident that Tammy’s expertise will help us maintain a culture centered on our IDEAL values—integrity, development, excellence, accountability and listening—for our teammates and customers,” Pesicka said in a news release. “We look forward to leveraging her insights and experience…

Iterative Scopes appoints new chief technology officer

[Image from Iterative Scopes]Iterative Scopes announced today that it appointed Aditya Khosla to its leadership team as the company’s chief technology officer.

The Cambridge, Massachusetts-based developer of artificial intelligence-based precision medicine for gastroenterology also added Khosla to its board of directors.

“We are thrilled to welcome Dr. Khosla to the Iterative Scopes team,” founder and CEO Jonathan Ng said in a news release. “Aditya brings a dedicated expertise in machine learning and improving patient outcomes with AI-powered healthcare technologies.”

As the company’s new CTO, Khosla will head up the company’s machine learning, product management and software engineering teams.

Before assuming this new role, Khosla was the co-founder and CTO of PathAI (co-founded in 2016), leading the engineering and IT, machine learning, product and recruiting teams.

“I’m excited to join Iterative Scopes as it makes signific…

Tandem Diabetes Care adds two new members to its board

Image from Tandem Diabetes

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed two new independent members to its board of directors.

Myoung Cha and Joao Malagueira have been named to the San Diego-based automated insulin delivery technology developer’s board, effective yesterday, June 15, 2022.

Get the full story at our sister site, Drug Delivery Business News.

Owen Mumford appoints new director of R&D

Owen Mumford announced today that it appointed Bal Johal as its director of research and development, effective next month.

Johal will become the director of R&D for the Woodstock, United Kingdom-based developer of medical devices, including the Aidaptus auto-injector, on July 4, 2022.

Get the full story at our sister site, Drug Delivery Business News.

Freudenberg Medical has a new CEO

Freudenberg Medical CEO Mark Ostwald [Image courtesy of Freudenberg Medical]

Freudenberg Medical (Beverly, Massachusetts) announced the recent promotion of Mark Ostwald into the corner office.

Ostwald was previously CTO of the business and part of its management board. He joined Freudenberg Medical in 2009, holding several leadership positions, including president of Europe, head of Minimally Invasive Solutions, and VP and GM of the Silicones Business Unit in California. He also helped establish the Kaiserslautern, Germany operation as managing director of Freudenberg Medical Europe.

Freudenberg Medical’s previous CEO Max Kley has been appointed CEO of a newly established Freudenberg business group for the fast-growing battery and fuel cell market. With more than 30 years of experience, the Freudenberg Group is positioning itself as a leader in the transition to carbon-neutral energy systems.

<…

Ocular Therapeutix adds two executives to leadership team

Ocular Therapeutix (Nasdaq:OCUL) announced today that it made two additions to its executive leadership team.

Bedford, Massachusetts-based Ocular Therapeutix appointed a chief medical advisor (CMA) — a newly created role — as well as a new chief medical officer (CMO). Additionally, the company created a new role called chief strategy advisor (CSA) for its departing CMO.

The company said in a news release that the realignment will enhance its ability to execute a strategy of building a comprehensive portfolio of assets to treat a range of ocular surface and back-of-the-eye retina diseases.

Dr. Peter Kaiser will advise the company in the new CMA role, with responsibilities centering around clinical development strategies for Ocular Therapeutix’s retina programs. He will also advise on pre-clinical development work for the company’s gene therapy delivery and complement inhibition development programs.

Kaiser agreed to serve in the role on…